{"doi":"10.1002/ana.26514","title":"Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients","abstract":"<jats:sec><jats:title>Objective</jats:title><jats:p>Neuronal excitation/inhibition (E/I) imbalance is a potential cause of neuronal network malfunctioning in Alzheimer's disease (AD), contributing to cognitive dysfunction. Here, we used a novel approach combining transcranial magnetic stimulation (TMS) and electroencephalography (EEG) to probe cortical excitability in different brain areas known to be directly involved in AD pathology.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We performed TMS‐EEG recordings targeting the left dorsolateral prefrontal cortex (l‐DLPFC), the left posterior parietal cortex (l‐PPC), and the precuneus (PC) in a large sample of patients with mild‐to‐moderate AD (n = 65) that were compared with a group of age‐matched healthy controls (n = 21).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We found that patients with AD are characterized by a regional cortical hyperexcitability in the PC and, to some extent, in the frontal lobe, as measured by TMS‐evoked potentials. Notably, cortical excitability assessed over the l‐PPC was comparable between the 2 groups. Furthermore, we found that the individual level of PC excitability was associated with the level of cognitive impairment, as measured with Mini‐Mental State Examination, and with corticospinal fluid levels of Aβ<jats:sub>42</jats:sub>.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Our data provide novel evidence that precuneus cortical hyperexcitability is a key feature of synaptic dysfunction in patients with AD. The current results point to the combined approach of TMS and EEG as a novel promising technique to measure hyperexcitability in patients with AD. This index could represent a useful biomarker to stage disease severity and evaluate response to novel therapies. ANN NEUROL 2023;93:371–383</jats:p></jats:sec>","journal":"Annals of Neurology","year":2023,"id":609709,"datarank":0.6414999178524083,"base_score":4.276666119016055,"endowment":4.276666119016055,"self_citation_contribution":0.6414999178524083,"citation_network_contribution":0.0,"self_endowment_contribution":0.6414999178524083,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":71,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1034329,"name":"Ilaria Borghi","orcid":"0000-0002-3058-3337","position":1,"is_corresponding":false},{"id":1034330,"name":"Michele Maiella","orcid":"0000-0003-4017-3769","position":2,"is_corresponding":false},{"id":1567232,"name":"Maria C. Pellicciari","orcid":null,"position":3,"is_corresponding":false},{"id":1567233,"name":"Sonia Bonnì","orcid":null,"position":4,"is_corresponding":false},{"id":464291,"name":"Lucia Mencarelli","orcid":"0000-0002-4006-4629","position":5,"is_corresponding":false},{"id":1034332,"name":"Martina Assogna","orcid":"0000-0002-8588-1112","position":6,"is_corresponding":false},{"id":1567234,"name":"Alessia D'Acunto","orcid":null,"position":7,"is_corresponding":false},{"id":1393975,"name":"Francesco Di Lorenzo","orcid":"0000-0003-4588-4041","position":8,"is_corresponding":false},{"id":1567235,"name":"Danny A. Spampinato","orcid":null,"position":9,"is_corresponding":false},{"id":106059,"name":"Emiliano Santarnecchi","orcid":"0000-0002-6533-7427","position":10,"is_corresponding":false},{"id":1567236,"name":"Alessandro Martorana","orcid":null,"position":11,"is_corresponding":false},{"id":106046,"name":"Giacomo Koch","orcid":"0000-0001-6155-9439","position":12,"is_corresponding":false},{"id":1034327,"name":"Elias Paolo Casula","orcid":"0000-0002-5039-973X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients","abstract":"<jats:sec><jats:title>Objective</jats:title><jats:p>Neuronal excitation/inhibition (E/I) imbalance is a potential cause of neuronal network malfunctioning in Alzheimer's disease (AD), contributing to cognitive dysfunction. Here, we used a novel approach combining transcranial magnetic stimulation (TMS) and electroencephalography (EEG) to probe cortical excitability in different brain areas known to be directly involved in AD pathology.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We performed TMS‐EEG recordings targeting the left dorsolateral prefrontal cortex (l‐DLPFC), the left posterior parietal cortex (l‐PPC), and the precuneus (PC) in a large sample of patients with mild‐to‐moderate AD (n = 65) that were compared with a group of age‐matched healthy controls (n = 21).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We found that patients with AD are characterized by a regional cortical hyperexcitability in the PC and, to some extent, in the frontal lobe, as measured by TMS‐evoked potentials. Notably, cortical excitability assessed over the l‐PPC was comparable between the 2 groups. Furthermore, we found that the individual level of PC excitability was associated with the level of cognitive impairment, as measured with Mini‐Mental State Examination, and with corticospinal fluid levels of Aβ<jats:sub>42</jats:sub>.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Our data provide novel evidence that precuneus cortical hyperexcitability is a key feature of synaptic dysfunction in patients with AD. The current results point to the combined approach of TMS and EEG as a novel promising technique to measure hyperexcitability in patients with AD. This index could represent a useful biomarker to stage disease severity and evaluate response to novel therapies. ANN NEUROL 2023;93:371–383</jats:p></jats:sec>","is_dataset_classified":null,"base_score":4.276666119016055,"endowment":4.276666119016055,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36134540","pmcid":"PMC10092632","openalex_id":"https://openalex.org/W4296619938","authors":[],"funders":[{"funder_name":"European Commission","grant_id":"857562","title":"Pan-European twinning to re-establish world-level Neuroscience Centre in Kiev (NEUROTWIN)"},{"funder_name":"Alzheimer&apos;s Drug Discovery Foundation","grant_id":"","title":null},{"funder_name":"BrightFocus Foundation","grant_id":"","title":null},{"funder_name":"European Research Council","grant_id":"","title":null},{"funder_name":"Ministero della Salute","grant_id":"","title":null}],"total_grants":5,"fwci":4.5795,"citation_percentile":0.95757211,"influential_citations":0,"citation_trend":[{"year":2023,"count":14},{"year":2024,"count":21},{"year":2025,"count":23},{"year":2026,"count":13}],"oa_status":"hybrid","license":"cc-by-nc","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26514","host_type":"journal"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26514","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26514","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ana.26514","host_type":"publisher"},{"url":"https://doi.org/10.1002/ana.26514","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36134540","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10092632","host_type":"repository"},{"url":"https://hdl.handle.net/11392/2498416","host_type":"repository"},{"url":"https://hdl.handle.net/2108/345971","host_type":"repository"},{"url":"https://hdl.handle.net/11573/1665518","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10092632/pdf/ANA-93-371.pdf","host_type":"repository"},{"url":"https://sfera.unife.it/bitstream/11392/2498416/2/Annals%20of%20Neurology%20-%202022%20-%20Casula%20-%20Regional%20Precuneus%20Cortical%20Hyperexcitability%20in%20Alzheimer%20s%20Disease%20Patients.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC10092632","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC10092632?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.1002/ana.26514","host_type":""},{"url":"https://onlinelibrary.wiley.com/doi/10.1002/ana.26514","host_type":""},{"url":"https://doi.org/https://doi.org/10.1002/ana.26514","host_type":""}],"fields_of_study":["Transcranial Magnetic Stimulation Studies","Functional Brain Connectivity Studies","Dementia and Cognitive Impairment Research","03 medical and health sciences","0302 clinical medicine","Humans","Alzheimer Disease","Parietal Lobe","Electroencephalography","Evoked Potentials","Transcranial Magnetic Stimulation"],"mesh_terms":["Alzheimer Disease","Electroencephalography","Evoked Potentials","Humans","Parietal Lobe","Transcranial Magnetic Stimulation"],"keywords":["Precuneus","Transcranial magnetic stimulation","Neuroscience","Electroencephalography","Posterior cingulate","Dorsolateral prefrontal cortex","Psychology","Temporal lobe","Alzheimer's disease","Medicine","Disease","Cortex (anatomy)","Cognition","Prefrontal cortex","Stimulation","Epilepsy","Internal medicine","Alzheimer Disease; Electroencephalography; Evoked Potentials; Humans; Parietal Lobe; Transcranial Magnetic Stimulation","TMS; Alzheimer's Disease; EEG","Settore M-PSI/03 - Psicometria","610","600","Alzheimer Disease","Parietal Lobe","Humans","Evoked Potentials","Research Articles"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"nct"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-31T13:36:40.354964Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}